Around 1 million people in the state have Type 2 Diabetes — and close to a quarter million more likely have it and don’t know, according to the Georgia Department of Public Health.
Drug company Merck is awaiting word on its emergency use authorization application for its recently announced drug molnupiravir. If approved, the anti-viral drug developed at a lab at Emory University could become the first-ever pill to treat COVID-19. The latest Georgia Today podcast examines the journey that led to this potential breakthrough and its connection to Emory.
Researchers at Atlanta’s Emory University were the ones who invented a promising antiviral drug in the fight against COVID-19 — a pill that pharmaceutical giant Merck & Co. said on Friday reduced hospitalizations and deaths by half in people recently infected with the coronavirus.
The number of COVID-19 patients hospitalized inside Emory Healthcare has jumped nearly fivefold since early June, straining the state’s largest health system as its doctors, nurses and staff work around-the-clock tending to sick patients, according to data shown to GPB News.
